Versant Capital Management’s KalVista Pharmaceuticals KALV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$11.6K Buy
1,024
+45
+5% +$509 ﹤0.01% 1824
2025
Q1
$11.3K Buy
979
+813
+490% +$9.38K ﹤0.01% 1665
2024
Q4
$1.41K Buy
+166
New +$1.41K ﹤0.01% 2128